These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16762476

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of furanocoumarins from apiaceous vegetables on the catalytic activity of recombinant human cytochrome P-450 1A2.
    Kang AY, Young LR, Dingfelder C, Peterson S.
    Protein J; 2011 Oct; 30(7):447-56. PubMed ID: 21847668
    [Abstract] [Full Text] [Related]

  • 4. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM, Bammler TK, Hayes JD, Eaton DL.
    Cancer Res; 1996 May 15; 56(10):2306-13. PubMed ID: 8625305
    [Abstract] [Full Text] [Related]

  • 5. Dietary modulation of the biotransformation and genotoxicity of aflatoxin B(1).
    Gross-Steinmeyer K, Eaton DL.
    Toxicology; 2012 Sep 28; 299(2-3):69-79. PubMed ID: 22640941
    [Abstract] [Full Text] [Related]

  • 6. Development of an on-line high performance liquid chromatography detection system for human cytochrome P450 1A2 inhibitors in extracts of natural products.
    Jeurissen SM, Claassen FW, Havlik J, Bouwmans EE, Cnubben NH, Sudhölter EJ, Rietjens IM, van Beek TA.
    J Chromatogr A; 2007 Feb 02; 1141(1):81-9. PubMed ID: 17184784
    [Abstract] [Full Text] [Related]

  • 7. Expression of human microsomal epoxide hydrolase in Saccharomyces cerevisiae reveals a functional role in aflatoxin B1 detoxification.
    Kelly EJ, Erickson KE, Sengstag C, Eaton DL.
    Toxicol Sci; 2002 Jan 02; 65(1):35-42. PubMed ID: 11752683
    [Abstract] [Full Text] [Related]

  • 8. Metabolism of promutagens catalyzed by Drosophila melanogaster CYP6A2 enzyme in Saccharomyces cerevisiae.
    Saner C, Weibel B, Wurgler FE, Sengstag C.
    Environ Mol Mutagen; 1996 Jan 02; 27(1):46-58. PubMed ID: 8625948
    [Abstract] [Full Text] [Related]

  • 9. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets.
    Lampe JW, King IB, Li S, Grate MT, Barale KV, Chen C, Feng Z, Potter JD.
    Carcinogenesis; 2000 Jun 02; 21(6):1157-62. PubMed ID: 10837004
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of aflatoxin B1 mutagenicity by cyclopiazonic acid in the presence of human liver preparations.
    Sabater Vilar M, Kuilman-Wahls ME, Fink-Gremmels J.
    Toxicol Lett; 2003 Aug 28; 143(3):291-9. PubMed ID: 12849689
    [Abstract] [Full Text] [Related]

  • 11. Analysis of cellular responses to aflatoxin B(1) in yeast expressing human cytochrome P450 1A2 using cDNA microarrays.
    Guo Y, Breeden LL, Fan W, Zhao LP, Eaton DL, Zarbl H.
    Mutat Res; 2006 Jan 29; 593(1-2):121-42. PubMed ID: 16122766
    [Abstract] [Full Text] [Related]

  • 12. DNA recombination induced by aflatoxin B1 activated by cytochrome P450 1A enzymes.
    Sengstag C, Würgler FE.
    Mol Carcinog; 1994 Dec 29; 11(4):227-35. PubMed ID: 7999264
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide.
    Wei X, Dai R, Zhai S, Thummel KE, Friedman FK, Vestal RE.
    J Pharmacol Exp Ther; 1999 May 29; 289(2):853-8. PubMed ID: 10215663
    [Abstract] [Full Text] [Related]

  • 14. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells.
    Van Vleet TR, Klein PJ, Coulombe RA.
    J Toxicol Environ Health A; 2002 Jun 28; 65(12):853-67. PubMed ID: 12079611
    [Abstract] [Full Text] [Related]

  • 15. Biochemical basis for the extreme sensitivity of turkeys to aflatoxin B(1).
    Klein PJ, Buckner R, Kelly J, Coulombe RA.
    Toxicol Appl Pharmacol; 2000 May 15; 165(1):45-52. PubMed ID: 10814552
    [Abstract] [Full Text] [Related]

  • 16. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
    Sengstag C, Eugster HP, Würgler FE.
    Carcinogenesis; 1994 May 15; 15(5):837-43. PubMed ID: 8200084
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of butylated hydroxytoluene chemoprevention of aflatoxicosis--inhibition of aflatoxin B1 metabolism.
    Guarisco JA, Hall JO, Coulombe RA.
    Toxicol Appl Pharmacol; 2008 Mar 15; 227(3):339-46. PubMed ID: 18177683
    [Abstract] [Full Text] [Related]

  • 18. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
    Yamada K, Hakura A, Kato TA, Mizutani T, Saeki K.
    Mutat Res; 2005 Sep 05; 586(1):87-95. PubMed ID: 16087391
    [Abstract] [Full Text] [Related]

  • 19. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
    Saito J, Sakai Y, Nagase H.
    Mutat Res; 2006 Oct 10; 609(1):68-73. PubMed ID: 16884943
    [Abstract] [Full Text] [Related]

  • 20. Cytochrome P450 2A13 mediates aflatoxin B1-induced cytotoxicity and apoptosis in human bronchial epithelial cells.
    Yang XJ, Lu HY, Li ZY, Bian Q, Qiu LL, Li Z, Liu Q, Li J, Wang X, Wang SL.
    Toxicology; 2012 Oct 28; 300(3):138-48. PubMed ID: 22743290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.